Matters of legal in nature including licensing, intellectual property, and lawsuits.
Basel, 17 July 2017 Roche’s OCREVUS (ocrelizumab) approved for relapsing and primary progressive multiple sclerosis in Australia Second approval after the US for OCREVUS as the first and only approved treatment for people with primary progressive multiple sclerosis, a highly disabling form of MS Australia has among the highest prevalence of MS in the Southern... Read more
Basel, 17 July 2017 Roche’s OCREVUS (ocrelizumab) approved for relapsing and primary progressive multiple sclerosis in Australia Second approval after the US for OCREVUS as the first and only approved treatment for people with primary progressive multiple sclerosis, a highly disabling form of MS Australia has among the highest prevalence of MS in the Southern... Read more
Adult Thy1-EYFP H line mouse, in vivo (cranial window). Excitatory pyramidal neurons in Layer 5 partly express EYFP. Courtesy of Dr. Masahiro Fukuda and Prof. Haruo Kasai, Center for Disease Biology and Integrative Medicine, Faculty of Medicine, The University of Tokyo, Tokyo, Japan Advances in multiphoton microscopy instruments and technology are leading to unique insights... Read more
NEW YORK, NY, June 29, 2017 – Enzo Biochem Inc. (NYSE: ENZ) reported today that a federal judge for the U.S. District Court for the District of Delaware has entered an order in the actions entitled Enzo Life Sciences, Inc. v. Gen-Probe Incorporated, Enzo Life Sciences, Inc. v. Hologic, Inc., Enzo Life Sciences, Inc. v. Roche Molecular... Read more
Wednesday, July 12, 2017: 9 AM PST / 12 PM EST / 5 PM BST Advances in multiphoton microscopy instruments and technology are leading to unique insights into the cellular world. From live-cell imaging to three-dimensional reconstructions of cells and their organelles, researchers are taking full advantage of the power of multiphoton microscopy to enhance... Read more
June 27, 2017 MilliporeSigma Wins False Advertising Lawsuit Against Distributor of RephiLe Bioscience Lab Water Products Analis S.A. ordered to cease all illegal advertising following MilliporeSigma lawsuit Belgian distributor claimed RephiLe Bioscience’s lab water purification products were equivalent to MilliporeSigma’s Analis’ advertisements found misleading by Belgian court MilliporeSigma, a leading science and technology company, today... Read more
Basel, 27 June 2017 Fewer pills, more flexibility in dosing: Roche’s new Esbriet tablet formulation approved in Europe for mild to moderate idiopathic pulmonary fibrosis (IPF) New immediate-release tablet formulation of Esbriet offers a reduced pill burden for patients with idiopathic pulmonary fibrosis (IPF) People with IPF now have the option of taking one Esbriet... Read more
Basel, 27 June 2017 Fewer pills, more flexibility in dosing: Roche’s new Esbriet tablet formulation approved in Europe for mild to moderate idiopathic pulmonary fibrosis (IPF) New immediate-release tablet formulation of Esbriet offers a reduced pill burden for patients with idiopathic pulmonary fibrosis (IPF) People with IPF now have the option of taking one Esbriet... Read more